Skip to content

Reduction of antibiotic use by monitoring presepsin in patients with severe infections in ICU

Reduction of antibiotic use by monitoring presepsin in patients with severe infections in ICU

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900024391
Enrollment
Unknown
Registered
2019-07-09
Start date
2019-08-01
Completion date
Unknown
Last updated
2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Presepsin monitoring treatment group:Adjust antibiotics according to presepsin test results
Routine treatment group:Adjust antibiotics according to clinical manifestations

Sponsors

Beijing Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Severe sepsis patients admitted to ICU conform to the third international consensus definition of sepsis and septic shock (Sepsis-3) in 2016. Diagnostic criteria for sepsis is suspected or confirmed infections and a sharp increase in SOFA scores (organ dysfunction) above 2. 2. Aged older than 18 years, gender is not limited; 3. (1) Laboratory examination results of urine, cerebrospinal fluid, ascites, pleural effusion and secretions of infected lesions suggest infection. (2) Imaging findings of CT, X-ray, ultrasonography and MRI indicated infection, and excluded non-infectious causes. (3) Microbiological examination results of positive results of blood culture, sputum culture and other body fluid and secretion culture. Satisfy any one of the above provisions, with evidence of infection.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation patients; 2. Patients with various advanced tumors; 3. Patients staying in ICU for less than 2 days; 4. Patients with antibiotic allergy or allergic constitution; 5. Long-term use of immunosuppressive agents; 6. Other situations in which the researcher considers it impossible to be included in the group.

Design outcomes

Primary

MeasureTime frame
Number of days without antibiotics in 28 days;presepsin;

Secondary

MeasureTime frame
28-day mortaility;Basic clinical data and laboratory test results;

Countries

China

Contacts

Public ContactChunsheng Li

Beijing Friendship Hospital

lcscyyy@163.com+86 13681392380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026